Skip to main content
Clinical Trials/NCT04500964
NCT04500964
Completed
Not Applicable

Transcatheter Aortic Valve Replacement for Failed Transcatheter Aortic Valve. An International Registry

IRCCS Policlinico S. Donato1 site in 1 country173 target enrollmentJanuary 1, 2019

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Failed Transcather Aortic Valve
Sponsor
IRCCS Policlinico S. Donato
Enrollment
173
Locations
1
Primary Endpoint
Overall mortality
Status
Completed
Last Updated
2 years ago

Overview

Brief Summary

Patients with failed transcather aortic valve (stenotic, regurgitant, both) and indication to further transcatheter aortic valve replacement (TAVR).

The purpouse of this study is to evaluate the indication to a second TAVR, the selection criteria of the second transcatheter aortic valve, procedural and clinical outcomes.

The primary endpoint of the study is overall mortality and Cardiovascular mortality at 1 year

Registry
clinicaltrials.gov
Start Date
January 1, 2019
End Date
July 1, 2020
Last Updated
2 years ago
Study Type
Observational
Sex
All

Investigators

Sponsor
IRCCS Policlinico S. Donato
Responsible Party
Principal Investigator
Principal Investigator

Luca Testa

Interventional Cardiology

IRCCS Policlinico S. Donato

Eligibility Criteria

Inclusion Criteria

  • Patients with failed transcather aortic valve (stenotic, regurgitant, both) and indication to further transcatheter aortic valve replacement (TAVR).

Exclusion Criteria

  • Not provided

Outcomes

Primary Outcomes

Overall mortality

Time Frame: 1 year

Overall mortality and Cardiovascular mortality at 1 year

Secondary Outcomes

  • VARC-3 Events(1 year)

Study Sites (1)

Loading locations...

Similar Trials